Burkhart Erin (CIK 1927648) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-23). Recent activity: Buy GILD (2,223 shares), Sell GILD (768 shares), Sell BMRN (996 shares), Sell BMRN (1,786 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | GILEAD SCIENCES, INC. (GILD) | SVP, Controllership | Buy | 2,223 | $0 |
| 2026-09-23 | GILEAD SCIENCES, INC. (GILD) | SVP, Controllership | Sell | 768 | $117,251 |
| 2025-05-20 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Sell | 996 | $59,033 |
| 2025-05-20 | BIOMARIN PHARMACEUTICAL INC (BMRN) | GVP, Chief Accounting Officer | Sell | 1,786 | $105,928 |
来源：SEC Form 4 申报文件 · 截至 2026-09-23